Wheat peptide challenge in coeliac disease
- 1 March 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 343 (8900) , 758-761
- https://doi.org/10.1016/s0140-6736(94)91837-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.The Journal of Experimental Medicine, 1993
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Specificities of Monoclonal Antibodies to Domain I of α-GliadinsScandinavian Journal of Gastroenterology, 1993
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- CELL-MEDIATED IMMUNITY TO A SYNTHETIC GLIADIN PEPTIDE RESEMBLING A SEQUENCE FROM ADENOVIRUS 12The Lancet, 1987
- Possible role for a human adenovirus in the pathogenesis of celiac disease.The Journal of Experimental Medicine, 1984
- Amino-acid sequence of the coeliac active gliadin peptide B 3142Zeitschrift für Lebensmittel-Untersuchung und Forschung, 1984
- An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture.Journal of Clinical Investigation, 1974
- Large-Scale preparation of gliadin proteinsJournal of the Science of Food and Agriculture, 1973
- GLUTEN-INDUCED ENTEROPATHY THE EFFECT OF PARTIALLY DIGESTED GLUTENThe Lancet, 1959